List of Excipients in API ERYTHROMYCIN STEARATE
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing ERYTHROMYCIN STEARATE
Detailed excipient profiles for ERYTHROMYCIN STEARATE
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
ERYTHROMYCIN STEARATE drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | erythromycin stearate | 10544-594 |
| Arbor Pharmaceuticals Inc | erythromycin stearate | 24338-106 |
| PD-Rx Pharmaceuticals Inc | erythromycin stearate | 55289-112 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN STEARATE drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 7
ERYTHROMYCIN STEARATE drug variants containing D&C RED NO. 7
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | erythromycin stearate | 10544-594 |
| Arbor Pharmaceuticals Inc | erythromycin stearate | 24338-106 |
| PD-Rx Pharmaceuticals Inc | erythromycin stearate | 55289-112 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN STEARATE drug variants not containing D&C RED NO. 7
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLACRILIN POTASSIUM
ERYTHROMYCIN STEARATE drug variants containing POLACRILIN POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | erythromycin stearate | 10544-594 |
| Arbor Pharmaceuticals Inc | erythromycin stearate | 24338-106 |
| PD-Rx Pharmaceuticals Inc | erythromycin stearate | 55289-112 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN STEARATE drug variants not containing POLACRILIN POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
ERYTHROMYCIN STEARATE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Arbor Pharmaceuticals Inc | erythromycin stearate | 24338-106 |
| PD-Rx Pharmaceuticals Inc | erythromycin stearate | 55289-112 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN STEARATE drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | erythromycin stearate | 10544-594 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
ERYTHROMYCIN STEARATE drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | erythromycin stearate | 10544-594 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN STEARATE drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Arbor Pharmaceuticals Inc | erythromycin stearate | 24338-106 |
| PD-Rx Pharmaceuticals Inc | erythromycin stearate | 55289-112 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
ERYTHROMYCIN STEARATE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Arbor Pharmaceuticals Inc | erythromycin stearate | 24338-106 |
| PD-Rx Pharmaceuticals Inc | erythromycin stearate | 55289-112 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN STEARATE drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | erythromycin stearate | 10544-594 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONES
ERYTHROMYCIN STEARATE drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | erythromycin stearate | 10544-594 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN STEARATE drug variants not containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Arbor Pharmaceuticals Inc | erythromycin stearate | 24338-106 |
| PD-Rx Pharmaceuticals Inc | erythromycin stearate | 55289-112 |
| >Company | >Ingredient | >NDC |
Excipient focus: POWDERED CELLULOSE
ERYTHROMYCIN STEARATE drug variants containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Arbor Pharmaceuticals Inc | erythromycin stearate | 24338-106 |
| PD-Rx Pharmaceuticals Inc | erythromycin stearate | 55289-112 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN STEARATE drug variants not containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | erythromycin stearate | 10544-594 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
ERYTHROMYCIN STEARATE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Arbor Pharmaceuticals Inc | erythromycin stearate | 24338-106 |
| PD-Rx Pharmaceuticals Inc | erythromycin stearate | 55289-112 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN STEARATE drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | erythromycin stearate | 10544-594 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
ERYTHROMYCIN STEARATE drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | erythromycin stearate | 10544-594 |
| Arbor Pharmaceuticals Inc | erythromycin stearate | 24338-106 |
| PD-Rx Pharmaceuticals Inc | erythromycin stearate | 55289-112 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN STEARATE drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBIC ACID
ERYTHROMYCIN STEARATE drug variants containing SORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | erythromycin stearate | 10544-594 |
| Arbor Pharmaceuticals Inc | erythromycin stearate | 24338-106 |
| PD-Rx Pharmaceuticals Inc | erythromycin stearate | 55289-112 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN STEARATE drug variants not containing SORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOOLEATE
ERYTHROMYCIN STEARATE drug variants containing SORBITAN MONOOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | erythromycin stearate | 10544-594 |
| Arbor Pharmaceuticals Inc | erythromycin stearate | 24338-106 |
| PD-Rx Pharmaceuticals Inc | erythromycin stearate | 55289-112 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN STEARATE drug variants not containing SORBITAN MONOOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
ERYTHROMYCIN STEARATE drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | erythromycin stearate | 10544-594 |
| Arbor Pharmaceuticals Inc | erythromycin stearate | 24338-106 |
| PD-Rx Pharmaceuticals Inc | erythromycin stearate | 55289-112 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN STEARATE drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ERYTHROMYCIN STEARATE drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | erythromycin stearate | 10544-594 |
| Arbor Pharmaceuticals Inc | erythromycin stearate | 24338-106 |
| PD-Rx Pharmaceuticals Inc | erythromycin stearate | 55289-112 |
| >Company | >Ingredient | >NDC |
ERYTHROMYCIN STEARATE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
